Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary A Ulaner

Showing results (81-90 of 152) with videos related to

Pageof 16
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|October 15, 2020
<sup>18</sup>F-FDG PET/CT versus anatomic imaging for evaluating disease extent and clinical trial eligibility in Erdheim-Chester disease: results from 50 patients in a registry studyJulian Kirchner, Vaios Hatzoglou, Justin B Buthorn, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 1, 2016
(18)F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancerGary A Ulaner, Raychel Castillo, Debra A Goldman, et al.
EJNMMI Radiopharmacy and Chemistry|August 21, 2025
Enhanced contrast in FAP-targeting PET imaging with <sup>61</sup>Cu-labeled FAP inhibitors: development and preclinical evaluation of novel [<sup>61</sup>Cu]Cu-Kalios PET radioligandsJacopo Millul, Tais Basaco Bernabeu, Raghuvir H Gaonkar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 19, 2017
Long-Half-Life <sup>89</sup>Zr-Labeled Radiotracers Can Guide Percutaneous Biopsy Within the PET/CT Suite Without Reinjection of RadiotracerFrancois H Cornelis, Jeremy C Durack, Neeta Pandit-Taskar, et al.
Radiology|June 3, 2015
Prognostic Value of FDG PET/CT before Allogeneic and Autologous Stem Cell Transplantation for Aggressive LymphomaGary A Ulaner, Debra A Goldman, Craig S Sauter, et al.
JAMA Network Open|July 26, 2024
ER-Targeted PET for Initial Staging and Suspected Recurrence in ER-Positive Breast CancerGary A Ulaner, Mel Silverstein, Chaitali Nangia, et al.
PET Clinics|June 27, 2023
Other Novel PET Radiotracers for Breast CancerSophia R O'Brien, Rebecca Ward, Grace G Wu, et al.
Urologic Oncology|March 30, 2022
Value of MRI in evaluating urachal carcinoma: A single center retrospective studyJeeban P Das, Sungmin Woo, Soleen Ghafoor, et al.
Abdominal Radiology (New York)|September 26, 2018
Detection of recurrent pancreatic cancer: value of second-opinion interpretations of cross-sectional images by subspecialized radiologistsSandra Huicochea Castellanos, Giuseppe Corrias, Gary A Ulaner, et al.
Genes, Chromosomes & Cancer|August 3, 2004
Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomasGary A Ulaner, Andrew R Hoffman, Jesse Otero, et al.
Pageof 16

Showing results (81-90 of 152) with videos related to

Sort By:
Pageof 16
European Journal of Nuclear Medicine and Molecular Imaging|October 15, 2020
<sup>18</sup>F-FDG PET/CT versus anatomic imaging for evaluating disease extent and clinical trial eligibility in Erdheim-Chester disease: results from 50 patients in a registry studyJulian Kirchner, Vaios Hatzoglou, Justin B Buthorn, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 1, 2016
(18)F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancerGary A Ulaner, Raychel Castillo, Debra A Goldman, et al.
EJNMMI Radiopharmacy and Chemistry|August 21, 2025
Enhanced contrast in FAP-targeting PET imaging with <sup>61</sup>Cu-labeled FAP inhibitors: development and preclinical evaluation of novel [<sup>61</sup>Cu]Cu-Kalios PET radioligandsJacopo Millul, Tais Basaco Bernabeu, Raghuvir H Gaonkar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 19, 2017
Long-Half-Life <sup>89</sup>Zr-Labeled Radiotracers Can Guide Percutaneous Biopsy Within the PET/CT Suite Without Reinjection of RadiotracerFrancois H Cornelis, Jeremy C Durack, Neeta Pandit-Taskar, et al.
Radiology|June 3, 2015
Prognostic Value of FDG PET/CT before Allogeneic and Autologous Stem Cell Transplantation for Aggressive LymphomaGary A Ulaner, Debra A Goldman, Craig S Sauter, et al.
JAMA Network Open|July 26, 2024
ER-Targeted PET for Initial Staging and Suspected Recurrence in ER-Positive Breast CancerGary A Ulaner, Mel Silverstein, Chaitali Nangia, et al.
PET Clinics|June 27, 2023
Other Novel PET Radiotracers for Breast CancerSophia R O'Brien, Rebecca Ward, Grace G Wu, et al.
Urologic Oncology|March 30, 2022
Value of MRI in evaluating urachal carcinoma: A single center retrospective studyJeeban P Das, Sungmin Woo, Soleen Ghafoor, et al.
Abdominal Radiology (New York)|September 26, 2018
Detection of recurrent pancreatic cancer: value of second-opinion interpretations of cross-sectional images by subspecialized radiologistsSandra Huicochea Castellanos, Giuseppe Corrias, Gary A Ulaner, et al.
Genes, Chromosomes & Cancer|August 3, 2004
Divergent patterns of telomere maintenance mechanisms among human sarcomas: sharply contrasting prevalence of the alternative lengthening of telomeres mechanism in Ewing's sarcomas and osteosarcomasGary A Ulaner, Andrew R Hoffman, Jesse Otero, et al.
Pageof 16